# Study in Women on the Effect of JNJ-64530440 on Oral Contraceptive and Midazolam, and the Effect of a High-fat Meal on JNJ-64530440

> **NCT03890341** · PHASE1 · WITHDRAWN · sponsor: **Janssen Research & Development, LLC**

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Drospirenone/Ethinylestradiol
- **DRUG:** Midazolam
- **DRUG:** JNJ-64530440

## Key facts

- **NCT ID:** NCT03890341
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-06-01
- **Primary completion:** 2021-08-01
- **Final completion:** 2021-11-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Stopped due to a strategic decision.
- **Last updated:** 2021-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03890341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03890341, "Study in Women on the Effect of JNJ-64530440 on Oral Contraceptive and Midazolam, and the Effect of a High-fat Meal on JNJ-64530440". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03890341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*